SecBot SecBot
SECBOTREPLAY Home › Report › KPTI

KPTI · Karyopharm Therapeutics filed a prepackaged Chapter 11 bankruptcy on…

Karyopharm Therapeutics Inc. · 8-K filed Nov 2, 2026 at 21:58 ET

At the news

BEARISHIMPACT 10/10

8-K filed Nov 2, 2026 at 21:58 ET

Karyopharm Therapeutics filed a prepackaged Chapter 11 bankruptcy on November 2, 2026, supported by 100% of its secured creditors. The plan provides for a reorganization transaction merging the company with Ayrmid Ltd., where secured funded debt claims (~$276M) will be exchanged for 55% of NewCo common stock and contingent value rights tied to myelofibrosis sales. Existing common and preferred equity will be canceled with no recovery. A court-supervised sale process continues with a $335.4M minimum bid threshold. The company had $8.1M cash at filing against ~$390M in total funded debt obligations.

  • Filed prepackaged Chapter 11 on November 2, 2026 in the Southern District of Texas
  • Total funded debt obligations of approximately $390M: $146M 1L Term Loan, $16M 1.5L 2028 Notes, $114M 2L 2029 Notes, $114M RIFA
  • Company had $8.1M cash, cash equivalents, and investments as of the Petition Date
  • Existing common stock and preferred equity interests will be canceled with zero recovery

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access